Baxter(US:BAX) Globenewswireยท2025-10-24 12:09Core Viewpoint - A class action lawsuit has been filed against Baxter International Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International Inc., et al., No. 1:25-cv-12672 [3]. - Investors have until December 15, 2025, to request to be appointed to lead the case [3]. Group 2: Product Issues - Baxter's Novum IQ Large Volume pump, a key growth driver, has faced serious malfunctions, including under- and over-medication of patients, since its launch in Canada in 2020 [4][5]. - The company previously claimed that the Novum LVP had "the most advanced safety features" and would provide "a safer delivery of medication," which is now alleged to be misleading [5]. Group 3: Stock Impact - Following the announcement on July 31, 2025, that Baxter would "voluntarily and temporarily pause shipments and planned installations" of the Novum LVP, the stock price fell by $6.29, or over 22%, from $28.05 to $21.76 per share [6].